Merck & Co., Inc.
- SEC CIK
- 0000310158
- Latest filing
- Aug 7, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 13, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 14
- +2 vs. Q4 2025
- Portfolio value
- $349.4M
- +$73.2M (+26.5%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRNAModerna, Inc. | Stock | 2,308,190 | $117.3M | 33.6% | 00.0% | Unchanged | History |
| PSNLPersonalis, Inc. | COM | 14,044,943 | $89.5M | 25.6% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 772,165 | $64.3M | 18.4% | 00.0% | Unchanged | History |
| Entrada Therapeutics Inc29384C908 | CALL | 1,739,768 | $22.0M | 6.3% | 00.0% | Unchanged | – |
| EIKNEikon Therapeutics, Inc. | COM | 1,666,666 | $17.6M | 5.0% | +1,666,666 | New | History |
| AKTSAktis Oncology, Inc. | COM | 952,844 | $17.0M | 4.9% | +952,844 | New | History |
| ALECAlector, Inc. | COM | 3,545,719 | $7.62M | 2.2% | 00.0% | Unchanged | History |
| STROSutro Biopharma, Inc. | COM | 272,351 | $6.78M | 1.9% | 00.0% | Unchanged | History |
| EVAXEvaxion A/S | COM | 1,214,126 | $4.52M | 1.3% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 93,414 | $1.83M | 0.5% | 00.0% | Unchanged | History |
| XLOXilio Therapeutics, Inc. | COM | 105,982 | $891.3K | 0.3% | 00.0% | UnchangedConverted for a 1-for-14 split | History |
| CARMCarisma Therapeutics Inc. | COM | 1,473,240 | $47.9K | <0.1% | 00.0% | Unchanged | History |
| NEUPNeuphoria Therapeutics Inc. | COM | 10,027 | $40.8K | <0.1% | 00.0% | Unchanged | History |
| HURATuHURA Biosciences, Inc. | COM | 19,445 | $34.8K | <0.1% | +5,495+39.4% | Added | History |